logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

At the end of February, the net asset value per share of comprehensive assets of C FIN INT INV (00721) was approximately 0.02 Hong Kong dollars.

date
16:57 13/03/2026
avatar
GMT Eight
China Financial International (00721) announced that the unaudited net asset value per ordinary share as of February 28, 2026 is approximately 0.02 Hong Kong dollars.
C FIN INT INV (00721) announced that the unaudited net asset value per ordinary share of its comprehensive assets as of February 28, 2026 is approximately 0.02 Hong Kong dollars.
Related Articles
HK Stock
Shenyang Public Utility Development Co., Ltd. (00747) issued a profit warning, expecting pre-tax loss to increase by approximately 60% to 70% compared to 2025.
HK Stock
Yunji (02670) proposes to appoint Wang Kegui as a candidate for non-executive director.
HK Stock
"Strong partnership! AB&B BIO-TECH-B (02627) joins hands with Walvax Biotechnology to start the new journey of exporting third-generation flu vaccines."
Shenyang Public Utility Development Co., Ltd. (00747) issued a profit warning, expecting pre-tax loss to increase by approximately 60% to 70% compared to 2025.
HK Stock
Yunji (02670) proposes to appoint Wang Kegui as a candidate for non-executive director.
HK Stock
"Strong partnership! AB&B BIO-TECH-B (02627) joins hands with Walvax Biotechnology to start the new journey of exporting third-generation flu vaccines."
HK Stock
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
icon
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
icon
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
icon
11/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.